Patents by Inventor Steven E. Cwirla

Steven E. Cwirla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5723286
    Abstract: Peptides which bind to selected receptor molecules are identified by screening libraries which encode a random or controlled collection of amino acids. Peptides encoded by the libraries are expressed as fusion proteins of bacteriophage coat proteins, and bacteriophage particles are then screened against the receptors of interest. Peptides having a wide variety of uses, such as therapeutic or diagnostic reagents, may thus be identified without any prior information on the structure of the expected ligand or receptor molecule.
    Type: Grant
    Filed: June 20, 1990
    Date of Patent: March 3, 1998
    Assignee: Affymax Technologies N.V.
    Inventors: William J. Dower, Steven E. Cwirla, Ronald W. Barrett
  • Patent number: 5648458
    Abstract: The peptide HITWDQLWNVMN (SEQ ID NO: 4) and related peptides and peptidomimetics bind to endothelial leukocyte adhesion molecule 1 and block the binding of leukocytes to this important receptor and so can be used to ameliorate the detrimental effects of certain disease conditions.
    Type: Grant
    Filed: February 16, 1995
    Date of Patent: July 15, 1997
    Assignee: Affymax Technologies N.V.
    Inventors: Steven E. Cwirla, Ronald W. Barrett, William J. Dower, Christine L. Martens
  • Patent number: 5643873
    Abstract: Disclosed are peptides and peptide mimetics that bind selectins, including endothelial leukocyte adhesion molecule 1 (ELAM-1). Such peptides and peptide mimetics are useful in methods for blocking adhesion of leukocytes to the selectins for the purpose of inhibiting inflammation as well as in diagnostic methods employing labeled peptides and peptide mimetics that bind selectins for the purpose of determining the site of inflammation in mammals which inflammation is mediated by the presence of one or more selectins.
    Type: Grant
    Filed: May 11, 1994
    Date of Patent: July 1, 1997
    Assignee: Affymax Technologies N.V.
    Inventors: Ronald W. Barrett, Steven E. Cwirla, William J. Dower, Kerry J. Koller, Jung Lee, Christine L. Martens, Beatrice Ruhland-Fritsch
  • Patent number: 5580717
    Abstract: Nucleotide sequences encoding proteins of interest are isolated from DNA libraries using bacteriophage to link the protein to the sequence which encodes it. DNA libraries are prepared from cells encoding the protein of interest and inserted into or adjacent to a coat protein of a bacteriophage vector, or into a sequence encoding a protein which may be linked by means of a ligand to a phage coat protein. By employing affinity purification techniques the phage particles containing sequences encoding the desired protein may be selected and the desired nucleotide sequences obtained therefrom. Thus, for example, novel proteins such as monoclonal antibodies may be produced and conventional hybridoma technology avoided.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: December 3, 1996
    Assignee: Affymax Technologies N.V.
    Inventors: William J. Dower, Steven E. Cwirla
  • Patent number: 5432018
    Abstract: Peptides which bind to selected receptors are identified by screening libraries which encode a random or controlled collection of amino acids. Peptides encoded by the libraries are expressed as fusion proteins of bacteriophage coat proteins, and bacteriophage are then screened against the receptors of interest. Peptides having a wide variety of uses, such as therapeutic or diagnostic reagents, may thus be identified without any prior information on the structure of the expected ligand or receptor.
    Type: Grant
    Filed: June 20, 1991
    Date of Patent: July 11, 1995
    Assignee: Affymax Technologies N.V.
    Inventors: William J. Dower, Steven E. Cwirla, Ronald W. Barrett
  • Patent number: 5427908
    Abstract: Nucleotide sequences encoding proteins of interest are isolated from DNA libraries using bacteriophage to link the protein to the sequence which encodes it. DNA libraries are prepared from cells encoding the protein of interest and inserted into or adjacent to a coat protein of a bacteriophage vector, or into a sequence encoding a protein which may be linked by means of a ligand to a phage coat protein. By employing affinity purification techniques the phage particles containing sequences encoding the desired protein may be selected and the desired nucleotide sequences obtained therefrom. Thus, for example, novel proteins such as monoclonal antibodies may be produced and conventional hybridoma technology avoided.
    Type: Grant
    Filed: May 1, 1990
    Date of Patent: June 27, 1995
    Assignee: Affymax Technologies N.V.
    Inventors: William J. Dower, Steven E. Cwirla